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Augmentation of Keratinocyte Differentiation by the 
Epidermal Mitogen, 8-Promo-CAMP 
PHILIP S. L. TONG and CYNTHIA L. MARCELO* 
Department ,of Dermatology, University of Michigan Medical School, 
Ann Arbor, MI 48109, USA 
The effect of the epidermal mitogen, 8bromo-CAMP, on keratinocyte differentiation was 
studied. A 3X10d4 M dose of I-bromo-CAMP was added to primary neonatal mouse 
epidermal keratinocyte cultures that slowly proliferate, stratify and differentiate over 2-3 
weeks time. [3H]Thymidine autoradiography coupled with an NH4Cl plus reducing agent 
technic which separates basal and differentiating keratinocytes was used to determine the 
target cell for the I-bromo-CAMP mitogenic effect. A histologic stain and a four buffer 
protein extraction protocol, in conjunction with PAGE and fluorographic technics, were 
used to assess the differentiation of the cultures. The data indicated that 8-bromo-CAMP 
primarily stimulated the proliferation of the basal cell monolayer. Simultaneous with the 
mitogenic effect was an increase in the production of keratohyalin granule, keratin and cell 
envelope proteins, which are specific markers of epidermal differentiation. The results 
indicate that keratinocytes stimulated by the epidermal mitogen I-bromo-CAMP simulta- 
neously express differentiation-related processes. 
The effect of CAMP on proliferation appears to be cell-specific and concentra- 
tion-dependent. Numerous studies report that large increases in intracellular 
CAMP inhibit proliferation [ 1, 21, an event often accompanied by stimulation of a 
number of cell functions and of differentiation [3-8]. Almost as numerous are 
investigations demonstrating the hyperproliferative effect of CAMP on a number 
of cell types [9-141. 
CAMP, at low cellular concentrations, is an epidermal keratinocyte mitogen, 
both in vitro [15, 161 and in vivo [17, 181. CAMP has also been reported to 
stimulate epidermal keratinocyte differentiation, at least on a morphologic level 
[15, 171. We have used neonatal mouse primary cultures which show a hyperpro- 
liferative response to 8-bromo-CAMP [15, 191 to study the effect of CAMP on the 
production of specific epidermal keratinocyte proteins. 
The neonatal mouse keratinocyte cultures start as a basal cell monolayer. The 
cultures stratify, forming 7-8 cell layers and the cells contain specific epidermal 
keratinocyte structures, such as desmosomal complexes, keratin filaments and 
keratohyalin granules. The differentiation proteins forming these structures can 
be separated into six fractions using a procedure recently described by us [20]. 
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Table 1. Epidermal protein fractions of neonatal mouse keratinocyte culture 
Fraction 
Desig- 












s2 1 M KP04, pH 7.0 
R2 1 M KPO.,, pH 7.0 
s3 
s4 
1% SDS, 0.05 M NaP04, 
pH 7.0 




8 M urea, 0.1 M 2-mercapto- 
ethanol, 0.001 M or=dithio- 
threitol, 0.05 M NaPQ4, 
pH 7.0 
8 M urea, 0.1 M 2-mercapto- 
ethanol, 0.001 M or+-dithio- 
threitol, 1% SDS, 0.05 M 
NaP04, pH 7.0 
Proteins that remain in 





SDS soluble proteins from 
non-enveloped cells 
Labelled by a brief 
exposure to 
[3H]amino acids 
Labelled only after 
a long chase period 
Insoluble, high MW 
structure; does not 
enter 5 % acrylamide gel 
a All extraction buffers were supplemented with 10 ug/ml PMSF, a proteinase inhibitor. 
Using SDS polyacrylamide gel electrophoresis (SDS-PAGE) and fluorographic 
technics we have studied the effect of a mitogenic dose of 8-bromo-CAMP on the 
production by epidermal keratinocytes of specific epidermal proteins. Our results 
indicated that 8-bromo-CAMP stimulated both epidermal keratinocyte prolifera- 
tion and differentiation. Thus, epidermal keratinocyte cultures can express differ- 
entiation-associated processes while actively proliferating. 
MATERIALS AND METHODS 
Reagents and Animals 
Day-old neonatal BALB/c mice were bred in a colony maintained at the University of Michigan, 
Department of Dermatology. Medium 199 (modified, Earle’s salts, glutamine), fetal bovine serum 
(FBS) and other medium components, were purchased from Flow Laboratories, Rockville, MD. 
Ultrapure urea was from Schwarz-Mann, Spring Valley, N.Y. 8-Bromoadenosine 3’:5’-cyclic mono- 
phosphate, sodium salt (I-bromo-CAMP) and 8-bromoguanosine 3’:S’-cyclic monophosphate, Na salt 
(8-bromo-cGMP), were obtained from Sigma Chemical Co., St Louis, MO. 
All materials for electrophoresis were purchased from Bio-Rad Laboratories, Richmond, Calif. 
Phenyl methylsulfonyl fluoride (PMSF) was from Calbiochem (San Diego, Calif.). All other chemicals 
used were obtained from Matheson, Coleman and Bell, East Rutherford, N.J. L-[4,5-3H]Leucine, 170 
Ci/mmol, 1 mCi/ml was purchased from Radiochemical Centre, Amersham, UK. [Methyl-‘HI- 
thymidine, 78.2 Ci/mmol, 1 mCi/ml and EN3HANCE were purchased from New England Nuclear, 
Boston, Mass. Coming plastic products (Coming, N.Y.) were used in all phases of cell isolation and 
growth. Nuclear ‘Back photographic emulsion (NTB) and X-Omat X-ray film were obtained from 
Kodak, Rochester, N.Y. 
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Epidermal Keratinocyte Cultures 
Primary keratinocyte cultures were prepared from neonatal mouse skin as previously described 
[19]. 5x lo6 viable basal cells were plated in 60 mm Petri dishes and grown in medium 199 supplement- 
ed with 13% (v/v) FBS plus 50 IU/ml of penicillin and 50 ug/ml streptomycin. The cultures were 
grown at 32°C under 5 % CO* humidified gassing, and were fed every other day. 
Kreyberg Staining of Keratinocyte Cultures 
The Kreyberg stain was used to differentiate basal cells (cytoplasm and nuclei stain blue) from 
suprabasal, and differentiated cells which stain a red erythrosin color [19]. 
Addition of Cyclic Nucleotide Analogs 
Twenty four hours after plating 3 x 10m4M 8bromo-CAMP was added to the cultures and with each 
medium change. 
Measurement of DNA Synthesis 
Neonatal mouse keratinocyte cultures have very minimal de novo synthesis of DNA precursors 
[21], so that [3H]thymidine labelling of DNA via the salvage pathway is a reliable index of DNA 
synthesis and of cell proliferation in these cells. Cultures grown on coverslips were labelled for 16 h at 
32°C with 10 @i/ml of [3H]thymidine and autoradiography was done as previously described [19]. 
The data is expressed as per cent positive cells + SEM. 
Separation of Basal and Differentiating Keratinocytes 
The keratinocytes grow as multi-layered cultures [ 191. To separate the proliferating basal from the 
differentiating keratinocytes, cultures growing on coverslips were rinsed 2x with PBS and then 
incubated in a solution of 0.24 M NH,Cl, 0.1 M 2-mercaptoethanol, 0.25 M sucrose, pH 9.0 either for 
30 min or for 16 h at 4°C. After mechanical agitation, the differentiating keratinocytes were dislodged 
leaving the basal cells attached to the coverslips. The detached keratinocytes were squashed on a 
slide and both cell preparations were fixed. Kreyberg staining and autoradiography were then done on 
the cells. 
Extraction of [3H]Leucine-labelled Proteins from Keratinocyte Cultures 
After a 2 h pulse with 10 @J/ml r3H]leucine, five extraction buffers are used in series to separate 
the cell proteins into six fractions [20]. The buffers and the type of protein in each fraction are 
summarized in table 1. 
Quantitation of [3H]Leucine and of the Protein in the Fractions 
To compare control with treated cultures, we used the only parameter that does not change as the 
keratinocytes are affected by additives such as CAMP: the unit of one Petri dish containing an initial 
culture of 5~ lo6 cells [20]. The data is expressed as: (n) Total ug protein per dish or culture; (b) total 
cpm of [3H]leucine per dish or culture; (c) total ug protein or cpm [3H]leucine in a fraction per dish or 
culture. 
SDS-PAGE 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis and fluorography (SDS-PAGE) was 
done as described by Laemmli [22] and as previously reported by us [20]. Equal portions of a culture 
were run for each fraction, i.e., Ss protein extracted from ‘/4 Petri dish of a 2-day-old control and of 
an 8-bromo-CAMP-treated culture was run. The intensities of the protein bands thus allow a visual 
comparison of the polypeptides. For fluorography, the gels were impregnated with EN3HANCE, 
dried and were exposed to X-Omat x-ray film at -70°C for l-2 weeks. 
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Fig. I. Autoradiograms of basal keratinocytes and integrity of differentiating cell layers from control 
and cyclic nucleotide treated cultures. (a, 6) 16day-old cultures were pulsed with 10 uCi/ml ?Hlthy- 
midine for 16 h and the differentiating layers were removed using an NH,Cl+2-mercaptoethanol 
solution. (a) Control: 4.3%fO.S labelling index; (6) 3~10~~ M 8-bromo-CAMP: 50%+4 labelling 
index. (c, d, e) Kreyberg-stained 12-day-old control cultures. 10M6 M 8-bromo-cGMP was used as an 
additional control; the effect is specific to CAMP. Bar, (a, b) 45 urn; (c-e) 60 urn. (a, b) x225; (c-e) 
x85. 
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Fig. 2. Protein fractions extracted from control, and gbromo-CAMP-treated cultures. 2-, 5- and 12- 
day-old control and 3x 1O-4 M I-bromo-CAMP-treated cultures were serially extracted and the total 
protein per fraction was determined. S 2, High salt soluble proteins; RZ, keratohyalin granule- 
associated proteins; S3, SDS-soluble proteins from viable, non-enveloped keratinocytes; S.,, non- 
covalently cross-linked keratins; S5, disultide cross-linked keratins; R5. cell envelope proteins. 
@---O, Control cultures; X-X, 3x 10e4 M I-bromo-CAMP added. 
RESULTS 
Effect of 8-Bromo-CAMP on [3H]Thymidine Labelling of Basal Keratinocytes 
Autoradiograms of control and 8-bromo-CAMP-treated epidermal keratinocyte 
cultures after removal of the differentiating cell layers are shown in fig. 1 a, b. 
The basal cell layer from the 16-day-old control cultures showed 4.3%+0.8 
labelling of the cells. The cultures grown in 3x 10V4 M 8-bromo-CAMP had a 
50%+4 labelling index. Some [3H]thymidine-labelled cells (estimated at 2-3 % of 
the population) were seen in differentiating cell preparations from both the 
control and 8-bromo-CAMP-treated cultures. 
Effect of 8-Bromo-CAMP on the Integrity of the Stratifying Cell Layers 
12-Day-old keratinocyte cultures show areas of detachment and of sloughing of 
fully differentiated cornified cells (fig. 1 c). 8-Bromo-CAMP-treated cultures re- 
tained the integrity of the upper cell layers (fig. 1 d, 12-day-old) for as along as 20 
days in culture (data not shown). Cultures treated with 8-bromo-cGMP, at its 
active dose of 10e6 M, were morphologically identical to the control cultures 
(fig. 1 e), indicating that the effect was specific to cGMP. 
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Fig. 3. Coomassie blue-stained SDS PAGE of control and 8-bromo-CAMP-treated cultures. ?-day-old 
basal cell, 5-day-old stratifying and 12-day-old fully differentiated keratinocytes were pulse labelled 
for 2 h with 10 @X/ml [“Hlleucine and extracted. Ten one-time-point experiments were done with the 
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Table 2. Effect of 8-bromo-CAMP on total protein and [3H]leucine incorporation 
in keratinocyte cultures 
Days after 







805 531 34 J 
1 039 1 536 48 t 




cpm of [3H]leucine/culture 
935 991 821 421 
540 321 765 851 




a 3 x 10m4 M 8-bromo-CAMP was added 1 day after plating, thus the cultures were grown for 1, 4 and 
11 days in the cyclic nucleotide. 
Ten 60 mm Petri dishes per time point were scraped and combined to yield enough protein for this 
and other analyses [20]. There was no change in the uptake of [3H]leucine by the 2-, .5- or 12-day-old 
I-bromo-CAMP-treated cultures, as determined by scintillation counting of the acid-soluble (6 % TCA) 
pools of parallel cultures. 
Analysis of the Proteins Extracted from Control and CAMP-Treated Cultures 
Cultures treated with 3 x 10e4 M 8-bromo-CAMP and control cultures were 
pulse labelled on day 2, 5 and 12 with 10 @i/ml of [3H]leucine. 
The quantities of total protein/culture and total cpm [3H]leucine/culture are 
presented in table 2. The amount of protein approximately doubled as the control 
keratinocytes grew from a basal cell monolayer to a fully differentiated 12-day- 
old culture. An initial decrease in the amount of total protein in the cultures, 
possibly resulting from the immediate CAMP mitogenic effect, or an effect on 
plating efficiency, was seen. This was probably not cytotoxic, since these prolif- 
erating cultures showed an increase in total protein of 48 % in the stratifying (day 
5) and 48% in the fully formed cultures (day 12). As the cultures grew, the 
amount of [3H]leucine incorporated into protein by the control culture cells 
decreased, as we have previously reported [20]. 8-Bromo-CAMP increased by 
42 % (day 5) and 29 % (day 12) the amount of [3H]leucine label in the proteins. 
In fig. 2, the amount of protein in the control and 8-bromo-CAMP-treated 
cultures per fraction is presented. As the control basal cell cultures stratified, the 
amount of high salt soluble (S,) and of keratohyalin granule macroaggregated 
2-day to 1Zday time period. I-Bromo-CAMP invariably induced the same effect presented in this 
figure, fig. 2 and table 2. (a) Sz, High salt extractable proteins; (b) R2, keratohyalin granule 
macroaggregates; (c) Ss, SDS-soluble, viable cell proteins; (d) S4, non-covalently-cross-linked kera- 
tins; (e) Ss, disulfide-cross-linked keratins; v) RJ, cell envelopes. Polypeptide band 0, intensity 
increased by 8-bromo-CAMP; )c, apparently induced by I-bromo-CAMP; 0, in control cultures not 
present in 8-bromo-treated cultures. 
Exp Cell Res 149 (1983) 
222 Tong and Marcel0 
a b 
Fig. 4. Fluorograms of SDS-PAGE of control and &bromo-CAMP-treated cultures. (a) S2, high salt- 
extractable proteins; (b) R2, keratohyalin granule macroaggregates; (c) Ss, viable cell proteins; (d) Sq, 
non-covalently cross-linked keratins. The S5, disultide cross-linked keratins, and cell envelope 
proteins (R5) from control cultures are not labelled during the 4 h hot and cold chase time period. 8- 
Bromo-CAMP treatment did not alter this observation. 
(R2) proteins approximately doubled (day 5). The non-cross-linked keratins (SJ, 
the disultide-cross-linked keratins (Ss) and the cell envelope proteins rapidly 
increased, by as much as 5-fold, as the control basal cell cultures differentiated. 
Concomitantly, the amount of viable cell, SDS-soluble protein (S3) decreased 
slightly by day 5, and by approx. 30% in the fully differentiated cultures. 
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8-Bromo-CAMP stimulated the production of the keratohyalin granule SZ and 
R2 proteins 1 S- to 2-fold and of the keratins (S4 and Ss), and of the cell envelope 
proteins (R& approx. 2- to 3-fold over the amounts of protein in the control 
cultures. The quantity of S3 viable cell proteins was decreased approx. 30% by 8- 
bromo-CAMP on day 2 and 5 of growth. 
SDS-PAGE and Fluorography of Proteins from Control and 
8-Bromo-CAMP-Treated Keratinocyte Cultures 
Coomassie blue-stained slab gels of proteins extracted from control and 8- 
bromo-CAMP-treated cultures are presented in fig. 3. All the fractions extracted 
from S-day-old and 12-day-old 8-bromo-CAMP-treated cultures, except for S3, 
contained more protein than the control cultures. The amount of a number of Sz 
and Rz polypeptides was increased by 8-bromo-CAMP treatment (fig. 3a and b, 
lane 4, solid circles). 8-Bromo-CAMP also apparently induced the synthesis of a 
number of other polypeptides, marked by asterisks in S2 (fig. 3 a, lane 4) and Rz 
(fig. 3 b, lane 4). The protein in a number of other bands extracted from 5-day-old 
8-bromo-CAMP-treated cultures was decreased when compared to the controls; 
these are indicated by open circles on the no. 3 control lanes (fig. 3 a, b). Within 
the limits of SDS PAGE resolution and visual scrutiny, fifteen bands in S2 and 
eleven bands in R2 were stimulated or induced by 8-bromo-CAMP, and nine Sz 
bands and eleven R2 polypeptides were inhibited by this CAMP analog. 
The non-cross-linked keratin fractions (S,) contains seven keratin polypep- 
tides, ranging in MW from 42.7 to 57.6 kD ([20], fig. 34. No difference in the 
polypeptide composition between the control and 8-bromo-CAMP-treated cul- 
tures was observed (fig. 3 d). The 12-day-old control cultures contain much more 
non-cross-linked keratin protein than the 2-day-old basal cell cultures [20]. Much 
larger amounts of these keratins were found in the 8-bromo-CAMP-treated kera- 
tinocytes (fig. 3 6). 8-Bromo-CAMP also increased the amounts of the disulfide- 
cross-linked keratins in the keratinocyte cultures (fig. 3 e). The cell envelope 
proteins (RJ do not even enter the stacking gel [20]. However, the amount of 
these proteins were also observed to be increased in 5-day-old 8-bromo-CAMP- 
treated cultures (arrow) (fig. 38. 
As presented in fig. 2, the SDS-soluble proteins (S,) decreased in amount as 2- 
day-old cultures stratified and differentiated (fig. 3 c). The 8-bromo-CAMP-treat- 
ed cells, especially the 2-day-old cultures, contained significantly less protein 
than the control cultures. 
Fluorograms of the protein fractions are presented in fig. 4. 8-Bromo-CAMP 
increased the labelling of the R2 keratohyalin granule macroaggregate fraction of 
5-day-old and IZday-old cultures, whereas no difference in [3H]leucine labelling 
of the S2 proteins was seen. The S4 non-disultide-cross-linked keratins extracted 
from the 8-bromo-CAMP-treated cultures also showed increased incorporation of 
the [3H]leucine label, especially by 2-day-old and 5-day-old cultures. As seen in 
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fig. 3 c, less intensely labelled bands were present in S3 cell soluble protein from 
the 8-bromo-CAMP-treated keratinocytes. 
DISCUSSION 
The epidermis is a tissue in dynamic equilibrium, i.e., the differentiated kera- 
tinocytes are continuously lost through shedding and are replaced by cells 
produced in the proliferative basal cell layer [23]. Cultured epidermal keratino- 
cytes likewise proliferate, maintaining a basal cell monolayer which supplies cells 
to the differentiating cell layers [ 191. 
Our work and that of a number of other investigators demonstrate that stimula- 
tion of the “second-messenger” CAMP system induces epidermal keratinocyte 
proliferation, both in vitro [IS, 161 and in vivo [17, 181. We present in this report 
evidence that the basal cell monolayer is the target cell for the CAMP mitogenic 
signal. 
8-Bromo-CAMP specifically caused a greater than lo-fold increase in the num- 
ber of [3H]thymidine-labelled cells in the basal cell layer of the cultures. Some 
3H-labelled cells were seen in the differentiating cell layers. These are either a 
small number of non-basal cells that, in vitro, maintained their proliferative 
capacity, or as suggested by Lavkar & Sun [25], are 3H-labelled basal keratino- 
cytes which were vertically displaced after mitosis. Specific antibody staining of 
these cells show they are basal epidermal keratinocytes [24]. 
Keratinocyte cultures undergoing CAMP-induced hyperproliferation show en- 
hanced overall culture stratification and differentiation, as seen in histologic and 
electron morphologic studies [15]. Our present studies showed that 8-bromo- 
CAMP increased the synthesis of keratohyalin granule-associated proteins and of 
keratin polypeptides. The amounts of all these proteins associated with epidermal 
differentiation [26-301 were induced by growing the cultures in a mitogenic dose 
of 8-bromo-CAMP. 
The CAMP-induced increase in the production of these proteins occurred 4 
days after adding the CAMP although the mitogenic effect of 8-bromo-CAMP 
occurs at earlier time points [15]. CAMP specifically has this effect: 8-Bromo- 
S’AMP did not induce the morphologic changes [15] and 10e6 M 8-bromo-cGMP 
caused no consistent change in the epidermal keratinocyte proteins [15]. 
8-Bromo-CAMP apparently induced the expression of (fig. 3, asterisk) and 
increased the amounts of (fig. 3, point) a number of polypeptides extracted into 
the keratohyalin granule-associated protein fractions (Sz+R2). This CAMP effect 
occurred in only these two fractions and the function of these induced polypep- 
tides is at present unknown. 
Other studies by us have concentrated on CAMP-dependent protein kinase 
phosphorylation of these same epidermal keratinocyte protein, since this is the 
only known mode of CAMP action [31]. We found that 8-bromo-CAMP induced 
32P-labelling of acidic proteins in the S2 keratohyalin granule fraction [32]. 
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Studies by Lonsdale-Eccles, Haugen & Dale [33] and Steinert et al. [30] have 
shown that a specific epidermal differentiation protein, named filaggrin (a histi- 
dine-rich protein), undergoes phosphorylation and dephosphorylation prior to 
integration into the stratum corneum, the uppermost epidermal layer. The 8- 
bromo-CAMP-induced polypeptides in the S2 fraction could be either polypeptide 
markers of differentiation, or mediators of CAMP action. 
Disulfide cross-linking of keratin polypeptides is part of the epidermal differen- 
tiation program [34]. The studies reported here and our other preliminary studies 
[32] showed that 8-bromo-CAMP did not affect this process, although very small 
differences beyond the detection limits of our technology may be occurring. 
Growth in 8-bromo-CAMP also specifically stabilized the integrity of the differ- 
entiating cell layers (fig. 1 c, d, e). The greater stability of the upper layers could 
easily result from an increased number of cells forming a better and tighter upper 
layer, i.e., a better “barrier” is produced. Alternatively, 8-bromo-CAMP may 
induce greater quantities of intercellular cementing substances, or may stimulate 
the formation of desmosomal complexes and cell junctions which are involved in 
the binding of epidermal keratinocyte cells [35]. 
The results presented in this report allow us to make the following conclusions. 
(1) CAMP has a mitogenic effect primarily (only?) on the epidermal basal cell. 
(2) The 8-bromo-CAMP-activated basal cells show accelerated proliferation. 
The progeny are most probably other basal cells and suprabasal cells capable of 
differentiating. 
(3) There is no evidence that 8-bromo-CAMP increases the synthesis per 
differentiating cell of keratins, cell envelopes and other differentiation marker 
proteins, although some polypeptides directly related to the mode of action of 
CAMP have been detected. 8-Bromo-CAMP appears to simply increase the num- 
ber of differentiating cells per culture. 
Thus the data supports the hypothesis that 8-bromo-CAMP stimulation of 
epidermal keratinocyte proliferation and differentiation results only from a mito- 
gen signal on the basal cell. Other epidermal keratinocyte mitogens, i.e., the 
tumor promotor tetradecanoyl phorbol acetate (Mar&o, unpublished data) and 
growth in low Ca2+ medium (36, 371, have different effects. These two mitogens 
significantly decrease epidermal differentiation. How the CAMP mitogen signal 
differs from the TPA and low Ca2+ mitogen effect on epidermal differentiation is 
presently being studied. 
The authors wish to thank Mary Anne Jordan for her technical assistance and excellent artistic 
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